Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
12.74
+0.17 (1.35%)
At close: Apr 28, 2026, 4:00 PM EDT
12.74
-0.01 (-0.04%)
After-hours: Apr 28, 2026, 4:01 PM EDT
Amneal Pharmaceuticals Employees
Amneal Pharmaceuticals had 8,700 employees as of December 31, 2025. The number of employees increased by 400 or 4.82% compared to the previous year.
Employees
8,700
Change (1Y)
400
Growth (1Y)
4.82%
Revenue / Employee
$346,984
Profits / Employee
$8,282
Market Cap
4.05B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Bausch Health Companies | 20,300 |
| Phibro Animal Health | 2,475 |
| Hims & Hers Health | 2,442 |
| Alkermes | 2,050 |
| HUTCHMED (China) | 1,796 |
| Lantheus Holdings | 1,193 |
| Supernus Pharmaceuticals | 778 |
| Prestige Consumer Healthcare | 600 |
AMRX News
- 6 days ago - Amneal Pharmaceuticals Transcript: M&A announcement - Transcripts
- 6 days ago - Amneal Pharma to buy Kashiv BioSciences in $1.1 billion deal - Reuters
- 6 days ago - Kashiv BioSciences Agrees to Be Acquired by Amneal Pharmaceuticals to Create a Fully Integrated Global Biosimilar Leader - Business Wire
- 6 days ago - Amneal Agrees to Acquire Kashiv BioSciences to Create Global Biosimilar Leader; Reports Strong Preliminary First Quarter 2026 Financial Results and Raises FY2026 Standalone Guidance - GlobeNewsWire
- 8 days ago - Amneal Announces Additional Positive Interim Phase 4 ELEVATE-PD Results with CREXONT® for Parkinson's Disease, Including Over 3 More Hours of Daily “Good On” Time When Switching from RYTARY® - GlobeNewsWire
- 14 days ago - Amneal Launches First Two Respiratory Metered-Dose Inhalation Products in the U.S. - GlobeNewsWire
- 19 days ago - Amneal Launches Bimatoprost Ophthalmic Solution, 0.01% - GlobeNewsWire
- 21 days ago - Amneal to Report First Quarter 2026 Results on May 1, 2026 - GlobeNewsWire